Comorbidity implications in brain disease: Neuronal substrates of symptom profiles

Neurotoxicity Research

Volumn 12, Issue 1, 2007, Pages 1-15

  Palomo, Tomas ^a   Beninger, Richard J ^b   Kostrzewa, Richard M ^c   Archer, Trevor ^d,e  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b QUEEN S UNIVERSITY   (Canada)

^c East Tennessee State University   (United States)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Affect; Cognition; Comorbidity; Neuroimaging; Neuronal systems; Regional selectivity; Sensitisation; Signalling; Stress

Indexed keywords

BIOGENIC AMINE; NEUROTRANSMITTER;

ARTICLE; BRAIN DISEASE; BRAIN ELECTROPHYSIOLOGY; COGNITIVE DEFECT; COMORBIDITY; DEGENERATIVE DISEASE; ENVIRONMENTAL STRESS; FRONTAL LOBE; HUMAN; IMMUNOPATHOGENESIS; MALADJUSTMENT; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPHARMACOLOGY; NEUROTRANSMISSION; OBSESSIVE COMPULSIVE DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE; COGNITION; MENTAL DISEASE; MOTOR ACTIVITY; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SYNAPTIC TRANSMISSION;

BRAIN DISEASES; COGNITION; COMORBIDITY; HUMANS; MENTAL DISORDERS; MOTOR ACTIVITY; NEURONS; SYNAPTIC TRANSMISSION;

EID: 34548608869     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033897     Document Type: Article

References (236)

1. Abbruzzese M, L Bellodi, S Ferri and S Scarone (1995) Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: A neuropsychological study. Brain Cogn. 27, 202-212.
2. Aber KM, MP Allin, K Kucharska-Pietura, C Andrew, S Williams, AS David and ML Phillips (2003) Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state. Hum. Brain Map 18, 135-145.
3. Abercrombie ED and BL Jacobs (1987) Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J. Neurosci. 7, 2837-2843.
4. Aharonovich E, E Nunes and D Hasin (2003) Cognitive impairment retention and abstinence among cocaine abusers in cognitive-behavioural treatment. Drug Alcohol Depend. 71, 207-211.
5. Akbarian S, WE Bunney Jr, SG Potkin, SB Wigal, JO Hagman, CA Sandman and EG Jones (1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50, 169-177.
6. Aloise F, G Penna, J Cerase, B Menendez Iglesias and L Adorini (1997) IL 12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159, 1604-1612.
7. Alonso M, LR Bevilaqua, I Izquierdo, JH Medina and M Cammarota (2003) Memory formation requires p38MAPK activity in the rat hippocampus. Neuroreport 14, 1989-1992.
8. Anderson SW, H Damasio, RD Jones and D Tranel (1991) Wisconsin CARD Sorting Test performance as a measure of frontal lobe damage. J. Clin. Exp. Neuropsychol. 13, 909-922.
9. Ardila A, M Roselli and S Strumwasser (1991) Neuropsychological deficits in chronic cocaine abusers. Int. J. Neurosci. 57, 73-79.
10. Austin MP, P Mitchell and GM Goodwin (2001) Cognitive deficits in depression: Possible implications for functional neuropathology. Br. J. Psychiatry. 178, 200-206.
11. Aylward RL and S Totterdell (1993) Neurons in the ventral subiculum, amygdala and entorhinal cortex which project to the nucleus accumbens: their input from somatostatin-immunoreactive boutons. J. Chem. Neuroanant. 6, 31-42.
12. Bartzokis G, PH Lu, M Beckson, R Rapaport, S Grant, EJ Wiseman and ED London (2000) Abstinence from cocaine reduces high-risk gambling responses on a Gambling Task. Neuropsychopharmacol. 22, 102-103.
13. Basso MR, HA Nasrallah, SC Olson and RA Bornstein (1998) Neuropsychological correlates of negative, disorganised and psychotic symptoms in schizophrenia. Schizophr. Res. 31, 99-111.
14. Bechara A, AR Damasio, H Damasio and SW Anderson (1994) Insensitivity to future consequences following damage to prefrontal cortex. Cognition 50, 7-15.
15. Bechara A, H Damasio, D Tranel and SW Anderson (1998) Dissociation of working memory from decision-making within the human prefrontal cortex. J. Neurosci. 18, 428-437.
16. Bechara A, D Tranel and H Damasio (2000) Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 123, 2189-2202.
17. Bechara A, S Dolan, N Denburg, A Hindes, SW Anderson and PE Nathan (2001) Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39, 376-389.
18. Beninger RJ (2006) Dopamine and incentive learning: A framework for considering antipsychotic medication effects. Neurotox. Res. 10, 199-210.
19. Berman DE and Y Dudai (2001) Memory extinction, learning anew, and learning the new: Dissociations in the molecular machinery of learning in cortex. Science 291, 2417-2419.
20. Berman I, B Viegner, A Mason, E Allan, D Pappas and AI Green (1997) Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr. Res. 25, 1-10.
21. Berman KF, RF Zec and DR Weinberger (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: II. Role of neuroleptic treatment, attention, and mental effort. Arch. Gen. Psychiatry 43, 126-135.
22. Berman KF, EF Torrey, DG Daniel and DR Weinberger (1992) Regional cortical blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch. Gen. Psychiatry 49, 927-934.
23. Berman KF, JL Osrem, C Randolph, J Gold, TE Goldberg, R Coppola, RE Carson, P Herscovitch and DR Weinberger (1995) Physiological activation of cortical networks during performance of the Wisconsin Card Sorting Test: A positron emission tomography study. Neuropsychologia 33, 1027-1046.
24. Bernabeu R, M Levi de Stein, C Fin, I Izquierdo and JH Medina (1995) Role of hippocampal NO in the acquisition and consolidation of inhibitory avoidance learning. Neuroreport 6, 1498-1500.
25. Bevilaqua LR, JS Bonini, JI Rossato, LA Izquierdo, M Cammarota and I Izquierdo (2006) The entorhinal cortex plays a role in extinction. Neurobiol. Learn Mem. 85(2), 192-1977. Epub 2005 Nov 14.
26. Bianchin M, RC Da Silva, PK Schmitz, JH Medina and I Izquierdo (1994) Memory of inhibitory avoidance in the rat is regulated by glutamate metabotropic receptors in the hippocampus. Behav Pharmacol. 5, 356-359.
27. Blanchard JJ and JM Neale (1994) The neuropsychological signature of schizophrenia: Generalized or differential deficit? Am. J. Psychiatry 151, 40-48.
28. Bolla KI, FR Funderburk and JL Cadet (2000) Differential effects of cocaine and concaine alcohol on neurocognitive performance. Neurology 45, 2285-2292.
29. Bolton D, P Raven, R Madronal-Luque and IM Marks (2000) Neurological and neuropsychological signs in obsessive compulsive disorder: Interaction with behavioural treatment. Behav. Res. Ther. 38, 695-708.
30. Braak H and K Del Tredici (2004) Alzheimer's disease: Intraneuronal alterations precede insoluble amyloid-β formation. Neurobiol. Aging 25, 713-718.
31. Braak H, E Braak and EM Mandelkow (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neurophil threads. Acta Neuropathol. 87, 554-567.
32. Braak H, K Del Tredici and E Braak (2000) Spectrum of pathology. In: Mild Cognitive Impairment (Peterson R, Ed.) (Oxford University Press: New York, NY), pp. 149-189.
33. Braak H, KD Del Tredici, U Rüb, RAI de Vos, ENH Jansen Steur and E Braak (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211.
34. Braff DL, R Heaton, J Kuck, M Cullum, J Moranville, I Grant and S Zisook (1991) The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch. Gen. Psychiatry 48, 891-898.
35. Brown AS, MD Begg, S Gravenstein, CA Schaefer, RJ Wyatt, M Bresnahan, VP Babulas and ES Susser (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61, 774-780.
36. Buchanan RW, K Vladar, PE Barta and GD Pearlson (1998) Structural evaluation of the prefrontal cortex in schizophrenia. Am. J. Psychiatry 155, 1049-1055.
37. Buka SL, MT Tsuang, EF Torrey, MA Klebanoff, D Berstein and RH Yolken (2001) Maternal infections and subsequent psychosis in the offspring. Arch. Gen. Psychiatry 58, 1032-1037.
38. Callaway CW, RL Hakan and SJ Henriksen (1991) Distribution of the amygdala input to the nucleus accumbens septi: An electrophysiological investigation. J. Neural Transm. Gen. Sect. 83, 215-225.
39. Cammarota M, LR Bevilaqua, JI Rossato, C Zinn, JH Medina and I Izquierdo (2007) MAPK and CaMKII-mediated events during memory formation, In: Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.), (Fundacion Cerebro y Mente: Madrid) (In press).
40. Campodonico JR, EH Aylward, AM Codori, C Young, L Krafft, M Magdalinski, N Ranen, P Slavney and J Brandt (1998) When does Huntington's disease begin? J. Int. Neuropsychol. Soc. 4, 467-473.
41. Carlsson A, N Waters, S Holm-Waters, J Tedroff, M Nilsson and ML Carlsson (2001) Interactions between monoamines, glutamate and GABA in schizophrenia: New evidence. Ann. Rev. Pharmacol. Toxicol. 41, 237-260.
42. Carpenter WT, JM Gold, AC Lahti, CA Queern RR Conley, JJ Bartko, J Kovnick and PS Appelbaum (2000) Decisional capacity for informed consent in schizophrenia research. Arch. Gen. Psychiatry 57, 533-538.
43. Carr DB, P O'Donnell, JP Card and SR Sesack (1999) Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens. J. Neurosci. 19, 11049-11060.
44. Caspi K, K Sugden, TE Moffitt A Taylor, IW Craig, H Harrington, J McClay, J Mill, A Martin, A Braithewaite and R Poulton (2003) Influence of life stress on depression: Moderation by a polymorphism in the 5.THH gene. Science 301, 386-389.
45. Cavedini P, R Giovanna, R Keller, A D'Annucci and L Bellodi (2002a) Frontal lobe dysfunction in pathological gambling patients. Biol. Psychiatry 51, 334-341.
46. Cavedini P, G Riboldi, A D'Annucci, P Belotti, M Cisima and L Bellodi (2002b) Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia 40, 205-211.
47. Chambers RA, JH Krystal and DW Self (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol. Psychiatry 50, 71-83.
48. Chambers RA, JR Taylor and MN Potenza (2003) Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. Am. J. Psychiatry 160, 1041-1052.
49. Coco ML, CM Kuhn, TD Ely and CD Kilts (1992) Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: Attenuation by diazepam. Brain Res. 590, 39-47.
50. Colder CR and L Chassin (1993) The stress and negative affect model of adolescent alcohol use and the moderating effects of behavioural undercontrol. J. Stud. Alcohol 54, 326-333.
51. Collier DA and T Li (2003) The genetics of schizophrenia: Glutamate not dopamine. Eur. J. Pharmacol. 480, 177-184.
52. Cook GS and AV Hill (2001) Genetics of susceptibility to human infectious diseases. Nat. Rev. Genetics 2, 967-977.
53. Correll CM, JA Rosenkranz and AA Grace (2005) Chronic cold stress alters prefrontal cortical modulation of amygdala neuronal activity in rats. Biol. Psychiatry 58, 382-391.
54. Coryell W, P Nopoulos, W Drevets, T Wilson and NC Andreasen (2005) Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: Diagnostic specificity and prognostic implications. Am. J. Psychiatry 162, 1706-1712.
55. Crombag HS, G Gorny, Y Li, B Kolb and TE Robinson (2005) Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb. Cortex 15, 341-348.
56. Crum RM, JC Anthony, SS Bassett and MF Folstein (1993) Population-based norms for the mini-mental state examination by age and educational level. JAMA 269, 2386-2391.
57. Cummings JL (1993) Mini-mental state examination: Norms, normals and numbers. JAMA 269, 2420-2421.
58. Davidson RJ, DC Jackson and NH Kalin (2000) Emotion, plasticity, context, and regulation: Perspectives from affective neuroscience. Psychol. Bull. 126, 890-909.
59. Davidson RJ, DA Lewis, LB Alloy, DG Amaral, G Bush, JD Cohen, WC Drevets, MJ Farah, J Kagan, JL McClelland, S Nolen-Hoeksema and BS Peterson (2002) Neural and behavioral substrates of mood and mood regulation. Biol. Psychiatry 52, 478-502.
60. Dierker LC, S Avenevoli, M Stolar and KR Merikangas (2002) Smoking and depression: An examination of mechanisms of com orbidity. Am. J. Psychiatry 159, 947-953.
61. Ding DC, PL Gabbott and S Totterdell (2001) Differences in the laminar origin of projections from the medial prefrontal cortex to the nucleus accum bens shell and core regions in the rat. Brain Res. 917, 81-89.
62. Donovan DM, DR Kivlahan and RD Walker (1984) Clinical limitations of neuropsychological testing in predicting treatment out come among alcoholics. Alcohol Clin. Exp. Res. 8, 470-475.
63. Drevets WC (2000) Neuroimaging studies of mood disorders. Biol. Psychiatry 48, 813-829.
64. Dudai Y (2002) Molecular bases of long-term memories: A question of persistence. Curr. Opin. Neurobiol. 12, 211-216.
65. Dudai Y (2004) The neurobiology of consolidations, or, how stable is the engram? Annu. Rev. Psychol. 55, 51-86.
66. Duka T, JM Townshend, K Collier and DN Stephens (2003) Impairment in cognitive function after multiple detoxifications in alcoholic inpatients. Alcohol Clin. Exp. Res. 27, 1563-1572.
67. Dunn AJ (1988) Stress-related activation of cerebral dopaminergic systems. Ann. NY Acad. Sci. 537, 188-205.
68. Eastwood SL and PJ Harrison (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res. Bull. 55, 569-578.
69. 2A receptors in the human cerebellum and alterations in schizophrenia. Synapse 42, 104-114.
70. Ebert D and KP Ebmeier (1996) The role of the cingulate gyrus in depression: From functional anatomy to neurochemistry. Biol. Psychiatry 39, 1044-1050.
71. Ebmeier KP and D Kronhaus (2002) Brain imaging and mood disorders, In: Biological Psychiatry (D'haenen H, JA den Boer and P Willner, Eds.) (Wiley & sons: London).
72. Ebmeier KP, E Rose E and D Steele (2006) Cognitive impairment and fMRI in major depression. Neurotox. Res. 10(2), 87-92.
73. Elliott R, KJ Friston and RJ Dolan (2000) Dissociable neural responses in human reward systems. J. Neurosci. 20, 6159-6165.
74. Elliott R, JS Rubensztein, BJ Sahakian and RJ Dolan (2002) The neural basis of mood-congruent processing biases in depression. Arch. Gen. Psychiatry 59, 597-604.
75. Espey MG, ON Chemyshev, JJ Reinhard, MA Namboodiri and CA Colton (1997) Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 8, 431-434.
76. Feigin AS, Y Ma, MF Ghilardi, M Fukuda, SM Ivanova, CP Ghez and D Eidelberg (2001) Abnornal thalamocortical activation responses during motor sequence learning in presymptomatic Huntington's disease. Soc. Neurosci. Abstr. 27.
77. Feldstein SN, FR Keller, RE Portman, RL Durham, KJ Klebe and PD Hasker (1999) A comparison of computerised and standard versions of the Wisconsin Card Sorting Test. Clin. Neuropsychol. 13, 303-313.
78. Finlay JM, MJ Zigmond and ED Abercrombie (1995) Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: Effects of diazepam. Neuroscience 64, 619-628.
79. Finlay JM, HP Jedema, AD Rabinovic, MJ Mana, MJ Zigmond and AF Sved (1997) Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress. J. Neurochem. 69, 144-150.
80. + kinetics and MPTP-induced nigrostriatal dopamine depletions. J. Pharmacol. Exp. Ther. 283, 100-107.
81. Fossati P, F Coyette, AM Ergis and JF Allilaire (2002) Influence of age and executive functioning on verbal memory of inpatients with depression. J. Affect. Disord. 68, 261-271.
82. Fossati P, PO Harvey, G Le Bastard, AM Ergis, R Jouvent and JF Allilaire (2004) Verbal memory performance of patients with a first depressive episode and patients with unipelar and bipolar recurrent depression. J. Psychiatr. Res. 38, 137-144.
83. Fredriksson A and T Archer (2006) Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice. Neurotox. Res. 10(2), 123-129.
84. French SJ and S Totterdell (2002) Hippocampal and prefrontal cortical inputs monosynaptically converge with individual projection neurons of the nucleus accumbens. J. Comp. Neurol. 446(2), 151-165.
85. French SJ and S Totterdell (2003) Individual nucleus accumbens-projection neurons receive both basolateral amygdala and ventral subicular afferents in rats. Neuroscience 119, 19-31.
86. Gehring WJ and AR Willoughby (2002) The medial frontal cortex and the rapid precessing of monetary gains and losses. Science 295, 2279-2282.
87. George TP and JH Krystal (2000) Comorbidity of psychiatric and substance abuse disorders. Curr. Opin. Psychiatry 13, 327-331.
88. Gilder DA, TL Wall and CL Ehlers (2004) Comorbidity of select anxiety and affective disorders with alcohol dependence in Southwest California Indians. Alcohol Clin. Exp. Res. 28, 1805-1813.
89. Glantz LA and DA Lewis (2000) Decreased dendritic spine density on prefrontal cortical neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65-73.
90. Glenn SW, OA Parsons, R Sinha and L Stevens (1988) The effects of repeated withdrawals from alcohol on the memory of male and female alcoholics. Alcohol Alcohol. 23, 337-342.
91. Gold JM and PD Harvey (1993) Cognitive deficits in schizophrenia. Psychiatr. Clin. North Am. 16, 295-312.
92. Goldberg TE, JR Kelsoe, DR Weinberger, NH Pliskin, PD Kirwin and KF Berman (1988) Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function. Int. J. Neurosci. 42, 51-58.
93. Goldberg TE, JD Ragland, EF Torrey, JM Gold, LB Bigelow and DR Weinberger (1990) Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch. Gen. Psychiatry 47, 1066-1072.
94. Goldberg TE, EF Torrey, JM Gold, JD Ragland, LB Bigelow and DR Weinberger (1993) Learning and memory in monozygotic twins discordant for schizophrenia. Psychol. Med. 23, 71-85.
95. Golik-Gruber V, D Brietenfeld, EN Gruber and D Karlovic (2003) Sulpiride psychopharmacotherapy in patients with alcohol addiction and depression comorbidity. Acta Clinica Croatia 42, 29-33.
96. Goto Y and AA Grace (2005) Dopamine-dependent interactions between limbic and prefrontal cortical synaptic plasticity in the nucleus accumbens: Disruption by cocaine sensitization. Neuron 47, 255-266.
97. Goto Y and Grace AA (2006) Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development. Biol. Psychiatry 2006 Aug 31; [Epub ahead of print]
98. Grace AA (2006) Disruption of cortical-limbic interaction as a substrate for comorbidity. Neurotox. Res. 10(2), 93-101.
99. Grace AA, H Moore and P O'Donnell (1998) The modulation of corticoaccumbens transmission by limbic afferents and dopamine: A model for the pathophysiology of schizophrenia. Adv. Pharmacol. 42, 721-724.
100. Grant BF (1995) Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey. J. Subst. Abuse 7, 481-497.
101. Grant I (1987) Alcohol and the brain: Neuropsychological correlates. J. Consult. Clin. Psychol. 55, 310-324.
102. Grant S, C Contoreggi and ED London (2000) Drug abusers show impaired performance in a laboratory test of decision-making. Neuropsychologia 38, 1180-1187.
103. Gray TS (1999) Functional and anatomical relationships among the amygdala, basal forebrain, ventral striatum, and cortex. An integrative discussion. Ann. NY Acad. Sci. 877, 439-444.
104. Gregson RAM and GM Taylor (1977) Prediction of relapse in men alcoholics. J. Stud. Alcohol 38, 1749-1760.
105. Gresch PJ, AF Sved, MJ Zigmond and JM Finlay (1994) Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. J. Neurochem. 63, 575-583.
106. Groenewegen HJ, Y Galis-de Graaf and WJ Smeets (1999) Integration and segregation of limbic cortico-striatal loops at the thalamic level: An experimental tracing study in rats. J. Chem. Neuroanat. 16(3), 167-185.
107. Hambrecht M and H Hafner (2000) Cannabis, vulnerability, and the onset of schizophrenia: An epidemiological perspective. Aust. NZ J. Psychiatry 34, 468-475.
108. Hambridge DM (1990) Intellectual impaitment in male alcoholics. Alcohol Alcohol. 25, 555-559.
109. Hariri AR, VS Mattay, A Tessitore, F Fera and DR Weinberger (2003) Neocortical modulation of the amygdala response to fearful stimuli. Biol. Psychiatry 53, 494-501.
110. Harrison PJ, AJ Law and SL Eastwood (2003) Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann. NY Acad. Sci. 1003, 94-101.
111. Harvey PO, G Le Bastard, JB Pochon, R. Levy, JF Allilaire, B Dubois and P Fossati (2004) Executive functions and up dating of the contents of working memory in unipolar depression. J. Psychiatr. Res. 38, 567-576.
112. Heaton RK (1981) Wisconsin Card Sorting Test Manual (PAR: Odessa, FL).
113. Higihara A, K Tarumi and K Nobutomo (2003) Positive and negative effects of social support on the relationship between work stress and alcohol consumption. J. Stud. Alcohol 64, 874-883.
114. Hill AV (1999) Genetics of infectious disease resistence. Curr. Opin. Genet. Dev. 6, 348-353.
115. Izquierdo I and JH Medina (1995) Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol. Learn. Mem. 63, 19-32.
116. Izquierdo I and JH Medina (1997) Memory formation: The sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol. Learn. Mem. 68, 285-316.
117. Izquierdo I, LRM Bevilaqua, JI Rossato, JS Bonini, WC Da Silva, JH Medina and M Cammarota (2006) The connection between the hippocampal and the striatal memory systems of the brain: A review of recent findings. Neurotox. Res. 10(2), 113-121.
118. Jedema HP, AF Sved, MJ Zigmond and JM Finlay (1999) Sensitization of norepinephrine release in medial prefrontal cortex: Effect of different chronic stress protocols. Brain Res. 830, 211-217.
119. Jedema HP, JM Finlay, AF Sved and AA Grace (2001) Chronic cold exposure potentiates CRH-evoked increases in electrophysiological activity of locus coeruleus neurons. Biol. Psychiatry 49, 351-359.
120. Johnson JG, P Cohen, DS Pine, DF Klein, S Kasen and JS Brook (2000) Association between cigarette smoking and anxiety disorders during adolescence and early childhood. JAMA 248, 2348-2351.
121. Johnson LR, RL Aylward, Z Hussain and S Totterdell (1994) Input from the amygdala to the rat nucleus accumbens: Its relationship with tyrosine hydroxylase immunoreactivity and identified neurons. Neuroscience 61, 851-865.
122. Katarina Z, K Andrew, M Filomena and H Xu-Feng (2004) Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 29, 619-625.
123. Kauer JA (2004) Learning mechanisms in addiction: Synaptic plasticity in the tegmental area as a result of exposure to drugs of abuse. Ann. Rev. Physiol. 66, 447-475.
124. Kendler KS, AC Heath, MC Neale, RC Kessler and LJ Eavea (1993) Alcoholism and major depression in women. A twin study of the causes of comorbidity. Arch. Gen. Psychiatry 50, 690-698.
125. Keuthen NJ, RL O'Sullivan and S Sprich-Buckminster (1998) Trichotillomania: Current issues in conceptualization and treatment. Psychother. Psychosom. 67, 202-213.
126. Knowlton BJ, JA Mangels and LR Squire (1996) A neostriatal habit learning system in humans. Science 273, 1399-1402.
127. Koponen H, P Rantakallio, J Veijola, P Jones, J Jokelainen and M Isohanni (2004) Childhood central nervous system infections and risk for schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 254, 9-13.
128. Koren D, WS Harrison, WS Kremen, JM Goldstein, SV Faraone, LJ Seidman, MJ Lyons, B Caplan and MT Tsuang (1998) Factor structure of the Wisconsin Card Sorting Test: Dimensions of deficit in schizophrenia. Neuropsychology 12, 289-302.
129. Kornhuber J, J Wiltfang and S Bleich (2004) The etiopathogenesis of schizophrenia. Pharmacopsychiatry 37(Suppl. 2), S103-S112.
130. Kroner S, JA Rosenkranz, AA Grace and G Barrionuevo (2005) Dopamine modulates excitability of basolateral amygdala neurons in vitro. J. Neurophysiol. 93, 1598-1610.
131. 4 receptor-dependent basolateral amygdala input. J. Neurosci. 25, 6066-6075.
132. Le Doux JE (2000) Emotion circuits in the brain. Ann. Rev. Neurosci. 23, 155-184.
133. Leber WR, OR Parsons and N Nichols (1985) Neuropsychological test results are related to ratings of men alcoholics' therapeutic progress: a replicated study. J. Stud. Alcohol 46, 116-121.
134. Leonard BE and A Myint (2006) Inflammation and depression: Is there a causal connection with dementia? Neurotox. Res. 10(2), 149-160.
135. Lewis DA, DW Volk and T Hashimoto (2004) Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: A novel target for the treatment of working memory dysfunction. Psychopharmacology 174, 143-150.
136. Loberg T and WR Miller (1986) Personality, cognitive and neuropsychological correlates of harmful alcohol consumption: A cross-national comparison of clinical samples. Ann. NY Acad. Sci. 472, 75-97.
137. Lochner C, S Seedat, PL du Toit, DG Nel, DJ Niehaus, R Sandler and DJ Stein (2005) Obsessive-compulsive disorder and trichotillomania: A phenomenological comparison. BMC Psychiatry 5, 2.
138. Mackenzie A, FR Funderburk, RP Allen and RL Stefan (1987) The characteristics of alcoholics frequently lost to followup. J. Stud. Alcohol 48, 119-123.
139. Mana MJ and AA Grace (1997) Chronic cold stress alters the basal and evoked electrophysiological activity of rat locus coeruleus neurons. Neuroscience 81, 1055-1064.
140. Maren S and GJ Quirk (2004) Neuronal signalling of fear memory. Nat. Rev. Neurosci. 5, 844-852.
141. Marenco S, R Coppola, DG Daniel, JR Zigun and DR Weinberger (1993) Regional cerebral blood flow during the Wisconsin Card Sorting Test in normal subjects as studied by xenon-133 dynamic SPECT: Comparison of absolute values, percent distribution values, and covariance analysis. Psychiatry Res. 50, 177-192.
142. Marien MR, M Briley and FC Colpaert (1993) Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. Eur. J. Pharmacol. 236, 487-489.
143. Mayberg HS (1997) Limbic-cortical dysregulation: A proposed model of depression. J. Neuropsychiatry Clin. Neurosci. 9, 471-481.
144. Mayberg HS (2003) Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment, In: Imaging Neuroscience: Clinical Frontiers for Diagnosis and Management (Frackowiak RS and T Jones, Eds.) (Oxford University Press: Oxford), pp 193-207.
145. Mazas C, PR Finn and JE Steinmetz (2000) Decision-making biases, antisocial personality, and early-onset alcoholism. Alcohol Clin. Exp. Res. 24, 1036-1040.
146. McClure SM, MK York and PR Montague (2004) The neural substrates of reward processing in humans: The modern role of fMRI. Neuroscientist 10, 260-268.
147. McGaugh JL (2000) Memory - a century of consolidation. Science 287, 248-251.
148. McGaugh JL and B Roozendaal (2002) Role of adrenal stress hormones in forming lasting memories in the brain. Curr. Opin. Neurobiol. 12, 205-210.
149. Medina JH, N Schröder and I Izquierdo (1999) Two different properties of short- and long-term memory. Behav. Brain Res. 103, 119-121.
150. Mednick SA, RA Machon, MO Huttunen and D Bonett (1988) Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45, 817-824.
151. Milad MR and GJ Quirk (2002) Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420, 70-74.
152. Miller CL, IC Llenos, JR Dulay, MM Barillo, RH Yolken and S Weis (2004) Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol. Dis. 15, 618-629.
153. Miller WR and CF Saucedo (1983) Assessment of neuropsychological impairment and brain damage in problem drinkers. In: Clinical Neuropsychology: Interface with Neurologic and Psychiatric Disorders (Golden CJ, JA Moses, JA Coffman, WR Miller and FD Strider, Eds.) (Grune and Stratton: New York), pp 141-195.
154. Modell JG, JM Mountz, GC Curtis and JF Greden (1989) Neurophysiologic dysfunction in basal ganglia/limbic striatal thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J. Neuropsychiatry Clin. Neurosci. 1, 27-36.
155. Moore H, HJ Rose and AA Grace (2001) Chronic cold stress reduces the spontaneous activity of ventral tegmental dopamine dopamine neurons Neuropsychopharmacology 24, 410-419.
156. Müller N (2004) Immunological and infections aspects of schizophrenia (Editorial). Eur. Arch. Psychiatry Clin. Neurosci., 254, 1-3.
157. Müller N and Schwarz M (2006) The immune function in schizophrenia: an inflammation-mediated dysbalance of the glutamatergic neurotransmission. Neurotox. Res. 10(2). 131-148.
158. Müller N, M Ackenheil, E Hofschuster, W Mempel and R Eckstrin (1991) Cellular immunity in schizophrenic patients before and during neuroleptic therapy. Psychiatry Res. 37. 147-160.
159. Müller N, M Empel, M Riedel, MJ Schwarz and M Ackenheil (1997a) Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 247, 308-313.
160. Müller N, P Dobmeier, M Empel, M Riedel, MJ, Schwarz and M Ackenheil (1997b) Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients. Eur. Psychiatry 12, 294-299
161. Müller N, M Hadjamn, M Riedel, J Primbs, M Ackenheil and R Gruber (1999) The adhesion-molecule receptor expression on T helper cells increases during treatment with neuroleptics and is related to the blood-brain barrier permeability in schizophrenia. Am. J. Psychiatry 156, 634-636.
162. Müller N, M Riedel, M Ackenheil and MJ Schwarz (2000) Cellular and humoral immune system in schizophrenia: A conceptual re-evaluation. World J. Biol. Psychiatry 1, 173-179.
163. Müller N, M Riedel, C Scheppach, B Brandstätter, S Sokkullu, K Krampe, M Olmschneider, H-J Möller and M Schwarz (2002) Beneficial anti-psychoyic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am. J. Psychiatry 159, 1029-1034.
164. Murphy FC, A Michael, TW Robbins and BJ Sahakian (2003) Neuropsychological impairment in patients with major depressive disorder: The effects of feedback on task performance. Psychol. Med. 33, 455-467.
165. Nisenbaum LK, MJ, Zigmond, AF Sved and ED Abeerombie (1991) Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J. Neurosci. 11, 1478-1484.
166. Nishi K, T Kondo and H Narabayashi (1991) Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa. Neurosci. Lett. 123, 244-247.
167. Numakawa T, Y Yagasaki, T Ishimoto, T Okada, T Suzuki, N Iwata, N Ozaki, T Taguchi, M Tatsumi, K Kamijima, RE Straub, DR Weinberger, H Kunugi and R Hashimoto (2004) Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 13, 2699-2708.
168. O'Donnell P and AA Grace (1995) Synaptic interactions among excitatory afferents to nucleus accumbens neurons: Hippocampal gating of prefrontal cortical input. J. Neurosci. 15, 3622-3639.
169. O'Farrell TT and JW Langenbucher (1985) Alcohol abuse, In: Practice of Inpatient Behavior Therapy: A Clinical Guide (Hersen M, Ed.) (Grune and Stratton: Orlando), pp 141-172.
170. O'Sullivan RL, CS Mansueto, EA Lerner and EC Miguel (2000) Characterization of trichotillomania. A phenomenological model with clinical relevance to obsessive-compulsive spectrum disorders. Psychiatr. Clin. North. Am. 23, 587-604.
171. Palomo T, T Archer, RJ Beninger and RM Kostrzewa (2004) Gene-environment interplay in neurogenesis and neurodegeneration. Neurotox. Res. 6(6), 415-434.
172. Pierri JN, AS Chaudry, TU Woo and DA Lewis (1999) Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am. J. Psychiatry 156, 1709-1719.
173. Pochon JB, R Levy, P Fossati, S Lehericy, JB Poline, B Pillon, D Le Bihan and B Dubois (2002) The neural system that bridges reward and cognition in humans: An fMRI study. Proc. Natl. Acad. Sci. USA 99, 5669-5674.
174. Porter RJ, P Gallagher, JM Thompson and AH Young (2003) Neurocognitive impairment in drug-free patients with major depressive disorder. Br. J.
175. Quirk GJ, GK Russo, JL Barron and K Lebron (2000) The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J. Neurosci. 20, 6225-6231.
176. Rajkowska G, JJ Miguel-Hidalgo, J Wei, G Dilley, SD Pittman, HY Meltzer, JC Overholser, BL Roth and CA Stockmeier (1999) Morphometric evidence for neuronal and glial profrontal cell pathology in major depression. Biol. Psychiatry 45, 1085-1098.
177. Ritter LM, JH Meador-Woodruff and GW Dalack (2004) Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia. Schizophr. Res. 68, 65-73.
178. Rodriguez-Moreno A, M Carrion and JM Delgado-Garcia (2006) The nicotinic agonist RJR-2403 compensates the impairment of eyeblink conditioning produced by the noncompetitive NMDA-receptor antagonist MK-801. Neurosci. Lett. 402(1-2), 102-107.
179. Rohsenow DJ (1982) Social anxiety, daily moods, and alcohol use over time among heavy social drinking men. Addict. Behav. 7, 311-315.
180. Romelsjo A and D Hasin (1992) The relationship between stressful working conditions and high alcohol consumption. Br. J. Addict. 87, 1173-1183.
181. Rose EJ, E Simonotto and KP Ebmeier (2005) Limbic overactivity in depression is associated with impaired working memory during the n-back task. Neuroimage 29(1), 203-215. Epub 2005 Sep. 12.
182. Rosenkranz JA and AA Grace (2001) Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J. Neurosci. 21, 4090-4103.
183. Rosenkranz JA and AA Grace (2002a) Ccellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J. Neurosci. 22, 324-337.
184. Rosenkranz JA and AA Grace (2002b) Dopamine-mediated modulation of odour-evoked amygdala potentials during Pavlovian conditioning. Nature 417, 282-287.
185. Rosenkranz JA and AA Grace (2003) Affective conditioning in the basolateral amygdala of anesthetized rats is modulated by dopamine and prefrontal cortical inputs. Ann. NY Acad. Sci. 985, 488-491.
186. Saoud M, T Hueber, H Mandran, J Dalery and T D'Amato (1998) Olfactory identification deficiency and WCST performance in men with schizophrenia. Psychiatry Res. 81, 251-257.
187. Sapolsky RM (1996) Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1, 1-19
188. Sapolsky RM (2001) Depression, antidepressants and the shrinking hippocampus. Proc. Natl. Acad. Sci. USA 98, 12320-12322.
189. Sapolsky RM (2005) The influence of social hierarchy on primate health. Science 308, 648-652.
190. Sapolsky RM, H Uno, CS Rebert and CE Finch (1990) Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10, 2897-2902.
191. Schmidt WJ and RJ Beninger (2006) Behavioural sensitization in addiction, schizophrenia, Farkinson's disease and dyskinesia. Neurotox. Res. 10(2), 161-166.
192. Schwab SG, M Knapp, S Mondabon, J Hallmayer, M Borrmann-Hassenbach, M Albus, B Lerer, M Rietschel, M Trixler, W Maier and DB Wildenauer (2003) Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72, 185-190.
193. Schwarcz R, A Rassoulpour, HQ Wu, D Medoff, CA Tamminga and RC Roberts (2001) Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50, 521-530.
194. Schwarz M, S Chiang, N Müller and M Ackenheil (2001) T-Helper-1 and T-Helper-2 responses in psychiatric disorders. Brain Behav. Immunol. 15, 340-370.
195. Shah PJ, KP, Ebmeier, ME Glabus MF Glabus and GM Goodwin (1998) cortical grey matter reductions associated with treatment-resistent chronic unipolar depression. Controlled magnetic resonance imaging study. Br. J. Psychiatry 172, 527-532.
196. Siegle GJ, SR Steinhauer, ME Thase, VA Stenger and CS Carter (2002) Can/ rst shake that feeling: Event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 51, 693-707.
197. Smelson DA, MF Losonczy, CW Davis, M Kaune, J Williams and D Ziedonis (2002) Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can. J. Psychiatry 47, 671-675.
198. Speciale C and R Schwarcz (1993) On the production and disposition of quinolinic acid in rat brain and liver slices. J. Neurochem. 60, 212-218.
199. Spedding M, I Neau and L Harsing (2003) Brain plasticity and pathology in psychiatric disease: Sites of action for potential therapy. Curr. Opin. Pharmacol. 3, 33-40.
200. Steele JD and SM Lawrie (2004) Segregation of cognitive and emotion function in the prefrontal cortex: A stereotactic meta-analysis. Neuroimage 21, 868-875.
201. Steele JD, M Meyer and KP Ebmeier (2004) Neural predictive error signal correlates with depressive illness severity in a game paradigm. Neuroimage 23, 269-280.
202. Stefansson H, E Sigurdsson, V Steinthorsdottir, S Björnsdottir, T Sigmundsson, S Ghosh, J Brynjolfsson, S Gunnarsdottir, O Ivarsson et al. (2002) Neureglin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892.
203. Stefansson H, J Sarginson, A Kong, P Yates, V Steinthorsdottir, E Gudfinnsson, S Gunnarsdottir, N Walker, H Petursson et al. (2003) Association of neureglin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 72, 83-87.
204. Stein DJ, D Simeon, LJ Cohen and E Hollander (1995) Trichotillomania and obsessive-compulsive disorder. J. Clin. Psychiatry 56, 28-34.
205. Stine OC, N Pleasant, ML Franz, MH Abbott, SE Folstein and CA Ross (1993) Correlation between onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet. 2, 1547-1549.
206. Swedo SE and HL Leonard (1992) Trichotillomania. An obsessive compulsive spectrum disorder? Psychiatr. Clin. North. Am. 15, 777-790.
207. Swendsen JD and KR Merikangas (2000) The comorbidity of depression and substance use disorders. Clin. Psychol. Rev. 20, 173-189.
208. Szechtman H and EZ Woody (2004) Obssessive-compulsive disorder as a disturbance of security motivation. Psychol. Rev. 111, 111-127.
209. Szechtman H and EZ Woody (2006) Obsessive-compulsive disorder as a disturbance of security motivation: Constraints on comorbidity. Neurotox. Res. 10(2), 103-112.
210. Taylor S, D McKay and JS Abramowitz (2005) Is obssessive-compulsive disorder as a disturbance of security motivation? Psychol. Rev. 112, 650-657.
211. Teichner G, MD Horner and RT Harvey (2001) Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. Int. J. Neurosci. 106, 253-263.
212. Teichner G, MD Horner, JC Roitzsh, J Herron and A Thevos (2002) Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict. Behav. 27, 751-763.
213. Tollefson GD (1996) Cognitive function in schizophrenic patients. J. Clin. Psychiatry 57(Suppl. 11), 31-39.
214. Totterdell S (2006) The anatomy of synaptic interactions in cortical and limbic regions. Neurotox. Res. 10(2), 65-86.
215. Totterdell S and GE Meredith (1997) Topographical organisation of projections from the entorhinal cortex to the striatum of the rat. Neuroscience 78, 715-729.
216. Totterdell S and AD Smith (1986) Cholecystokinin-immunoreactive boutons in synaptic contact with hippocampal pyramidal neurons that project to the nucleus accumbens. Neuroscience 19, 181-192.
217. Totterdell S and AD Smith (1989) Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. J. Chem. Neuroanat. 2, 285-298.
218. Tukel R, V Keser, N Karali, T Olgun and C Calikusu (2001) Comparison of clinical characteristics in trichotillomania and obsessive-compulsive disorder. J. Anxiety Disord. 15, 433-441.
219. Tukel R, A Polat, O Ozdemir, D Aksut and N Turksoy (2002) Comorbid conditions in obsessive-compulsive disorder. Compr. Psychiatry 43, 204-209.
220. Valenti O and AA Grace (2005) Chronic stress affects medial prefrontal cortex neuron activity. Neuropharmacology 49(Suppl.), 1-28.
221. van Minnen A, KA Hoogduin, GP Keijsers, I Hellenbrand and GJ Hendriks (2003) Treatment of trichotillomania with behavioral therapy or fluoxetine: A randomized, waiting-list controlled study. Arch. Gen. Psychiatry 60, 517-522.
222. Walker EF and D Difrio (1997) Schizophrenia: A neural diathesis-stress model. Psychol. Rev. 104, 667-685.
223. Waugh M, M Jackson, GA Fox, SH Hawke and RR Tuck (1989) Effect of social drinking on neuropsychological performance. Br. J. Addict. 84, 659-667.
224. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44, 660-669.
225. Weinberger DR, KF Berman and RF Zec (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional blood flow evidence. Arch. Gen. Psychiatry 43, 114-125.
226. Weinberger DR, KF Berman and BP Illowsky (1988) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism. Arch. Gen. Psychiatry 45, 609-615.
227. Westergaard T, PB Mortensen, CB Pedersen, J Wohlfart and M Melbye (1999) Exposure to prenatal and childhood infections and the risk of schizophrenia: Suggestions from a study of sibship characteristics and influenza prevalence. Arch. Gen. Psychiatry 56, 993-998.
228. Wilder KE, DR Weinberger and TE Goldberg (1998) Operant conditioning and orbitofrontal cortex in schizophrenic patients: Unexpected evidence for intact functioning. Schizophr. Res. 30, 169-174.
229. Williams NM, A Preece, G Spurlock, N Norton, HJ Williams, S Zammit, MC O'Donovan and MJ Owen (2003) Support genetic variation in neureglin 1 and susceptibility to schizophrenia. Mol. Psychiatry 8, 485-487.
230. Woo TU, RE Whitehead, DS Melchitzky and DA Lewis (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA 95, 5341-5346.
231. Woody EZ, V Lewis, L Snider, H Grant, M Kamath and H Szechtman (2005) Induction of compulsive-like washing by blocking the feeling of knowing: an experimental test of the security-motivation hypothesis of obsessive-compulsive disorder. Behav. Brain Funct. 1, 11.
232. Woody EZ and H Szechtman (2005) Motivation, time course, and heterogeneity in obsessive-compulsive disorder: Response to Taylor, McKay and Abramowitz (2005). Psychol. Rev. 112, 658-661.
233. Wright CI and HJ Groenewegen (1995) Patterns of convergence and segregation in the medial nucleus accumbens of the rat: Relationships of prefrontal cortical, midline thalamic, and basal amygdaloid afferents. J. Comp. Neurol. 361, 383-403.
234. Wright CI, AV Beijer and HJ Groenewegen (1996) Basal amydgdaloid complex afferents to the rat nucleus accumbens are compartmentally organised. J. Neurosci. 16, 1877-1893.
235. Xiao BG and H Link (1999) Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies? Immunol. Today 20, 477-479.
236. Ziedonis D, JM Williams and D Smelson (2003) Serious mental illness and tobacco addiction: A model program to address this common but neglected issue. Am. J. Med. Sci. 326, 223-230.